Qube Research & Technologies Ltd
- SEC CIK
- 0001729829
- Latest filing
- Aug 14, 2026
EBS holding history
Emergent BioSolutions Inc. in every 13F filed by Qube Research & Technologies Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EBS overviewAll 13F holders of EBSFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −167,057−100.0% | Sold out | Holders |
| Q3 2025 | 167,057 | $1.47M | <0.1% | −179,871−51.8% | Reduced | Holders |
| Q2 2025 | 346,928 | $2.21M | <0.1% | −740,415−68.1% | Reduced | Holders |
| Q1 2025 | 1,087,343 | $5.28M | <0.1% | +271,550+33.3% | Added | Holders |
| Q4 2024 | 815,793 | $7.80M | <0.1% | +477,845+141.4% | Added | Holders |
| Q3 2024 | 337,948 | $2.82M | <0.1% | +63,794+23.3% | Added | Holders |
| Q2 2024 | 274,154 | $1.87M | <0.1% | +274,154 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −621,177−100.0% | Sold out | Holders |
| Q4 2023 | 621,177 | $1.49M | <0.1% | +621,177 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −36,158−100.0% | Sold out | Holders |
| Q2 2023 | 36,158 | $265.8K | <0.1% | +36,158 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −135,889−100.0% | Sold out | Holders |
| Q4 2022 | 135,889 | $1.60M | <0.1% | +91,261+204.5% | Added | Holders |
| Q3 2022 | 44,628 | $937.0K | <0.1% | +22,089+98.0% | Added | Holders |
| Q2 2022 | 22,539 | $700.0K | <0.1% | +474+2.1% | Added | Holders |
| Q1 2022 | 22,065 | $906.0K | <0.1% | +22,065 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −14,355−100.0% | Sold out | Holders |
| Q3 2021 | 14,355 | $719.0K | <0.1% | +4,689+48.5% | Added | Holders |
| Q2 2021 | 9,666 | $609.0K | <0.1% | +9,666 | New | Holders |